---
title: "公共数据库+纯生信分析=IF 10+文章！单细胞数据结合泛癌和衰老热点竟然这么香"
date: 2023-11-15T00:58:45Z
draft: ["false"]
tags: [
  "fetched",
  "i生信"
]
categories: ["Acdemic"]
---
公共数据库+纯生信分析=IF 10+文章！单细胞数据结合泛癌和衰老热点竟然这么香 by i生信
------
<div><section><img data-ratio="0.4255555555555556" data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/uR5O2f9J2Ls7KaPdobh1zjAeaibo9mMHhPzgFOVH8xyFTYLib0cozKPV0pTrd7B1tEuWamxQ1GZtk83ucW6mZsmw/640?wx_fmt=png&amp;wxfrom=5&amp;wx_lazy=1&amp;wx_co=1" data-w="900" src="https://mmbiz.qpic.cn/sz_mmbiz_png/uR5O2f9J2Ls7KaPdobh1zjAeaibo9mMHhPzgFOVH8xyFTYLib0cozKPV0pTrd7B1tEuWamxQ1GZtk83ucW6mZsmw/640?wx_fmt=png&amp;wxfrom=5&amp;wx_lazy=1&amp;wx_co=1"></section><section data-tools="135编辑器" data-id="106062"><section><section><section><section><section data-brushtype="text"><span><strong>公</strong></span></section></section><section><br></section></section><section><section><section data-brushtype="text"><span><strong>告</strong></span></section></section><section><br></section></section><section><section><section data-brushtype="text"><span><strong>通</strong></span></section></section><section><br></section></section><section><section><section data-brushtype="text"><span><strong>知</strong></span></section></section><section><br></section></section></section><section><section><section data-autoskip="1"><section><strong><span>“小张聊科研”团队郑重声明</span></strong><span>：我公司对外联络的渠道为企业微信及企业邮箱，请大家认准</span><span><strong>@解颐生物</strong></span><span>的企业微信，及</span><strong><span>@joyebio.com</span></strong><span>的企业邮箱，其他任何私人联系方式联系您均为</span><strong><span>诈骗行为</span></strong><span>，请广大粉丝提高警惕。</span></section></section></section></section></section></section><p><span>今天跟大家分享一篇基于<strong><span>单细胞</span></strong>与</span><span><strong><span>bulk RNA数据</span></strong></span><span>进行纯生信数据挖掘，解析<strong><span>泛癌中肿瘤内皮细胞的衰老转录特征，及其对预后和免疫治疗影响</span></strong>的<strong><span>10+</span></strong>生信好文。文章标题：<strong><span>A transcriptomic pan-cancer signature for survival prognostication and prediction of immunotherapy response based on endothelial senescence</span></strong>.</span></p><p><img data-ratio="0.2337962962962963" data-s="300,640" data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/uR5O2f9J2LuY7BEZrtcceaY2Deoo5YjCX70VEeZ4IiaeVdUykTH3T1h50Cpj5dCAEKSk6A9rrYmlTUASHETgPSA/640?wx_fmt=png" data-type="png" data-w="864" src="https://mmbiz.qpic.cn/sz_mmbiz_png/uR5O2f9J2LuY7BEZrtcceaY2Deoo5YjCX70VEeZ4IiaeVdUykTH3T1h50Cpj5dCAEKSk6A9rrYmlTUASHETgPSA/640?wx_fmt=png"></p><section data-role="title" data-tools="135编辑器" data-id="132406"><section><section><section><span><strong>PART.</strong><strong>0</strong><strong data-original-title="" title="">1</strong></span></section><section><section><section><section><br></section><section><br></section></section><section><span><strong data-brushtype="text">研究背景</strong></span></section><section><section><br></section><section><br></section></section></section></section></section></section></section><p><strong><span>细胞衰老</span></strong><span>最近被纳入“</span><strong><span>癌症的特征</span></strong><span>”中。已有报道，</span><strong><span>肿瘤内皮细胞获得了衰老分泌相关表型</span></strong><span>，这个过程可能与</span><strong><span>“诱导血管生成”、“激活侵袭和转移”以及“促进肿瘤性炎症”</span></strong><span>等癌症特征相关，最终促进肿瘤生长和远处转移的形成。</span></p><p><span>因此作者推测</span><strong><span>肿瘤内皮细胞(Tumor Endothelial Cells, TEC)</span></strong><span>的</span><strong><span>衰老在实体肿瘤的进展和免疫治疗</span></strong><span>效果中起重要作用，可作为</span><strong><span>预后和免疫治疗反应的有效靶点</span></strong><span>。</span></p><section data-role="title" data-tools="135编辑器" data-id="132406"><section><section><section><span><strong>PART.</strong><strong>0</strong><strong data-original-title="" title="">2</strong></span></section><section><section><section><section><br></section><section><br></section></section><section><span><strong data-brushtype="text">研究思路</strong></span></section><section><section><br></section><section><br></section></section></section></section></section></section></section><p><span>作者通过公共数据库收集不同癌种的</span><strong><span>单细胞RNA数据集</span></strong><span>，进行了对</span><span><strong><span>细胞特异性衰老</span></strong></span><span>的分析，然后生成了一个</span><strong><span>跨癌种内皮衰老相关特征指标</span></strong><span>。最后利用这个特征指标，应用机器学习构建了</span><span><strong><span>生存预后和免疫治疗反应预测模型</span></strong></span><span>，并挖掘</span><strong><span>关键的预测标志物</span></strong><span>。</span></p><section data-role="title" data-tools="135编辑器" data-id="132406"><section><section><section><span><strong>PART.</strong><strong>0</strong><strong data-original-title="" title="">3</strong></span></section><section><section><section><section><br></section><section><br></section></section><section><span><strong data-brushtype="text">研究结果</strong></span></section><section><section><br></section><section><br></section></section></section></section></section></section></section><section data-role="title" data-tools="135编辑器" data-id="127142"><section><section><section><section><section><br></section></section><section><span><strong data-brushtype="text">评估肿瘤环境中细胞群体的衰老状态</strong></span></section></section><section><section data-width="100%"><br></section><section data-width="100%"><br></section></section></section></section></section><p><p></p><p><span>作者首先对公共数据库中15个癌种的18个单细胞数据集，进行</span></p><p><strong><span>细胞注释</span></strong></p><p><span>。然后基于衰老相关基因对这些细胞进行</span></p><p><p><strong><span>GSVA分析</span></strong></p></p><p><span>，发现在肿瘤环境中</span></p><p><strong><span>肿瘤内皮细胞（TEC）</span></strong></p><p><span>的比肿瘤细胞及其他细胞群体（包括髓样细胞、T细胞和B细胞）表现出</span></p><p><strong><span>更高的衰老评分</span></strong></p><p><span>。</span></p></p><p><p><span>为了进一步探索</span></p><p><strong><span>衰老TEC与其他细胞群体的相互作用</span></strong></p><p><span>，作者将TEC分为</span></p><p><strong><span>高衰老细胞（HS-TEC）</span></strong></p><p><span>和</span></p><p><p><strong><span>低衰老细胞（LS-TEC）</span></strong></p></p><p><span>，通过</span></p><p><strong><span>细胞互作网络分析</span></strong></p><p><span>发现，</span></p><p><strong><span>HS-TEC与免疫细胞有较强的相互作用</span></strong></p><p><span>。</span></p></p><p><img data-ratio="0.6345707656612529" data-s="300,640" data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/uR5O2f9J2LuY7BEZrtcceaY2Deoo5YjCEmJobXicFALeM7QkXBowxa52unM711sbiclR3gIvswsgC4Ku9yBeWOAA/640?wx_fmt=png" data-type="png" data-w="862" src="https://mmbiz.qpic.cn/sz_mmbiz_png/uR5O2f9J2LuY7BEZrtcceaY2Deoo5YjCEmJobXicFALeM7QkXBowxa52unM711sbiclR3gIvswsgC4Ku9yBeWOAA/640?wx_fmt=png"></p><section data-role="title" data-tools="135编辑器" data-id="127142"><section><section><section><section><section><br></section></section><section><span><strong data-brushtype="text">泛癌中内皮细胞衰老的转录状态</strong></span></section></section><section><section data-width="100%"><br></section><section data-width="100%"><br></section></section></section></section></section><p><p><span>作者通过</span></p><p><strong><span>相关性分析</span></strong></p><p><span>筛选与TEC衰老评分正相关的基因，以及</span></p><p><strong><span>差异分析</span></strong></p><p><span>获得在内皮细胞中差异上调的基因，再进一步相关性分析及取交集获得102个基因作为特定的</span></p><p><strong><span>内皮细胞衰老调控基因（EC.SENESCENCE.SIG）</span></strong></p><p><span>。</span></p></p><p><p></p><p><strong><span>GO富集分析</span></strong></p><p><span>发现EC.SENESCENCE.SIG主要富集在</span></p><p><strong><span>与细胞黏附和相互作用相关的通路上</span></strong></p><p><span>。</span></p></p><p><img data-ratio="0.902088772845953" data-s="300,640" data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/uR5O2f9J2LuY7BEZrtcceaY2Deoo5YjC0FUglib0q8E2icYgP6ic15kCuweNS5ttIFuhbEe9APDibFSPDu92KxwMPg/640?wx_fmt=png" data-type="png" data-w="766" src="https://mmbiz.qpic.cn/sz_mmbiz_png/uR5O2f9J2LuY7BEZrtcceaY2Deoo5YjC0FUglib0q8E2icYgP6ic15kCuweNS5ttIFuhbEe9APDibFSPDu92KxwMPg/640?wx_fmt=png"></p><section data-role="title" data-tools="135编辑器" data-id="127142"><section><section><section><section><section><br></section></section><section><span><strong data-brushtype="text">探究EC.SENESCENCE.SIG与肿瘤预后及免疫的关系</strong></span></section></section><section><section data-width="100%"><br></section><section data-width="100%"><br></section></section></section></section></section><p><p><span>进一步分析发现EC.SENESCENCE.SIG在不同实体瘤，包括</span></p><p><strong><span>肾细胞肾癌（KIRC）、胰腺癌（PAAD）和甲状腺癌（THCA）</span></strong></p><p><span>，表现出</span></p><p><strong><span>更高的EC.SENESCENCE.SIG分数</span></strong></p><p><span>，而</span></p><p><p><strong><span>大B细胞淋巴瘤（DLBC）和急性髓系白血病（LAML）</span></strong></p></p><p><span>在内的血液系统恶性肿瘤显示</span></p><p><p><strong><span>较低的分数</span></strong></p></p><p><span>。</span></p><p></p></p><section><p><span>最后，将TCGA全癌症队列的患者按照EC.SENESCENCE.SIG的</span></p><p><strong><span>GSVA分数</span></strong></p><p><span>（中位数）分为高分和低分两组，结果发现</span></p><p><strong><span>高GSVA得分与较差的总体生存（OS）</span></strong></p><p><span>显着相关。免疫浸润分析发现高GSVA分数</span></p><p><strong><span>与免疫细胞明显改变的肿瘤浸润相关</span></strong></p><p><span>。特别是，在几乎所有癌症类型中，GSVA分数与</span></p><p><strong><span>M2巨噬细胞（促肿瘤）肿瘤浸润</span></strong></p><p><span>呈正相关，并与</span></p><p><p><strong><span>CD8+ T细胞（抗肿瘤）肿瘤浸润</span></strong></p></p><p><span>呈负相关。</span></p></section><p><img data-ratio="0.6809744779582366" data-s="300,640" data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/uR5O2f9J2LuY7BEZrtcceaY2Deoo5YjCbMUTCGtTAD8tUQ5l3qSwVx8JXnhicIlmundfrZ67a5lhgQXQVdjZIdw/640?wx_fmt=png" data-type="png" data-w="862" src="https://mmbiz.qpic.cn/sz_mmbiz_png/uR5O2f9J2LuY7BEZrtcceaY2Deoo5YjCbMUTCGtTAD8tUQ5l3qSwVx8JXnhicIlmundfrZ67a5lhgQXQVdjZIdw/640?wx_fmt=png"></p><section data-role="title" data-tools="135编辑器" data-id="127142"><section><section><section><section><section><br></section></section><section><span><strong data-brushtype="text">基于EC.SENESCENCE.SIG预测免疫治疗反应</strong></span></section></section><section><section data-width="100%"><br></section><section data-width="100%"><br></section></section></section></section></section><section><span lang="EN-US"><p></p></span></section><p><p><span>上述已知</span></p><p><strong><span>高EC.SENESCENCE.SIG得分与肿瘤免疫细胞浸润失衡相关</span></strong></p><p><span>，因此作者推测这个特征指标还可以</span></p><p><strong><span>预测对于抗PD-L1/PD-1或抗CTLA-4免疫检查点抑制剂治疗的反应</span></strong></p><p><span>。</span></p></p><p><p><span>作者首先评估了TCGA数据中</span></p><p><strong><span>EC.SENESCENCE.SIG和TMB之间的相关性</span></strong></p><p><span>，发现</span></p><p><strong><span>TMB</span></strong></p><p><span>与多数癌种中的EC.SENESCENCE.SIG呈负相关，表明EC.SENESCENCE.SIG可以</span></p><p><strong><span>预测免疫治疗的反应</span></strong></p><p><span>。</span></p></p><p><p><span>进一步用</span></p><p><strong><span>免疫治疗的数据集</span></strong></p><p><span>发现与对免疫疗法应答的患者相比，</span></p><p><strong><span>耐药患者</span></strong></p><p><span>中的EC.SENESCENCE.SIG得分更高。</span></p></p><p><p><span>最后，使用了十种不同的</span></p><p><strong><span>机器学习算法</span></strong></p><p><span>，</span></p><p><strong><span>构建预测模型</span></strong></p><p><span>，并估计了这些模型的</span></p><p><p><strong><span>预测性能</span></strong></p></p><p><span>。</span></p></p><p><p><span>总之，EC.SENESCENCE.SIG也是一种</span></p><p><strong><span>可靠的全癌症预测模型</span></strong></p><p><span>，可用于预测</span></p><p><strong><span>抗PD-L1/PD1或抗CTLA-4</span></strong></p><p><span>免疫治疗反应。</span></p></p><p><img data-ratio="0.7830626450116009" data-s="300,640" data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/uR5O2f9J2LuY7BEZrtcceaY2Deoo5YjClQyuExbqHIcabIbQrV0hvOQTDjZLv20MkSicpY3pWPk0MtvEYJREn6g/640?wx_fmt=png" data-type="png" data-w="862" src="https://mmbiz.qpic.cn/sz_mmbiz_png/uR5O2f9J2LuY7BEZrtcceaY2Deoo5YjClQyuExbqHIcabIbQrV0hvOQTDjZLv20MkSicpY3pWPk0MtvEYJREn6g/640?wx_fmt=png"></p><section data-role="title" data-tools="135编辑器" data-id="127142"><section><section><section><section><section><br></section></section><section><span><strong data-brushtype="text">EC.SENESCENCE SIG相关泛癌预后模型的构建与验证</strong></span></section></section><section><section data-width="100%"><br></section><section data-width="100%"><br></section></section></section></section></section><p><p><span>为了优化EC.SENESCENCE.SIG用于</span></p><p><strong><span>全癌症预后预测</span></strong></p><p><span>，作者将EC.SENESCENCE.SIG的102个基因纳入</span></p><p><strong><span>LASSO分析</span></strong></p><p><span>中，再进一步构建</span></p><p><p><strong><span>Cox比例风险回归模型</span></strong></p></p><p><span>。然后，根据风险评分的中位值将TCGA的患者分为</span></p><p><strong><span>高低风险组</span></strong></p><p><span>，并比较</span></p><p><p></p></p><p><p><span><strong><span>组间患者生存差异</span></strong></span></p></p><p><p></p></p><p><span>。最后纳入</span></p><p></p><p><strong><span>临床特征</span></strong></p><p></p><p><span>，生成了一个结合了临床疾病分期和EC.SENESCENCE.SIG相关风险评分的</span></p><p><strong><span>nomogram评分</span></strong></p><p><span>。</span></p></p><p><p><span>评估发现这个nomogram评分</span></p><p><strong><span>在不同实体癌症的外部验证数据集中</span></strong></p><p><span>均显示了</span></p><p><strong><span>良好的预测性能</span></strong></p><p><span>。</span></p></p><p><img data-ratio="1.2590529247910864" data-s="300,640" data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/uR5O2f9J2LuY7BEZrtcceaY2Deoo5YjCO9C7aJu9zoH8DI5r8TnWuXIEmmb8NBOGGRvuwWGHzdHYxicWU3RygIw/640?wx_fmt=png" data-type="png" data-w="718" src="https://mmbiz.qpic.cn/sz_mmbiz_png/uR5O2f9J2LuY7BEZrtcceaY2Deoo5YjCO9C7aJu9zoH8DI5r8TnWuXIEmmb8NBOGGRvuwWGHzdHYxicWU3RygIw/640?wx_fmt=png"></p><section data-role="title" data-tools="135编辑器" data-id="127142"><section><section><section><section><section><br></section></section><section><span><strong data-brushtype="text">挖掘预后模型中的关键生物标志物</strong></span></section></section><section><section data-width="100%"><br></section><section data-width="100%"><br></section></section></section></section></section><section><p><span>为了</span></p><p><strong><span>促进EC.SENESCENCE.SIG在生存预后评估中的临床应用</span></strong></p><p><span>，作者使用了三种基于机器学习的算法，包括</span></p><p><strong><span>随机森林，XGBoost和LASSO特征选择</span></strong></p><p><span>，从EC.SENESCENCE.SIG的所有基因中选择最重要的标志。三种算法取交集得到了三个共同的基因，</span></p><p><strong><span>ITGA5，TGM2，FSCN1</span></strong></p><p><span>。</span></p></section><section><p><span>接下来，分析了这三个基因</span></p><p><strong><span>在癌与癌旁的表达差异</span></strong></p><p><span>。发现与正常组织相比，</span></p><p><strong><span>FSCN1</span></strong></p><p><span>在</span></p><p><strong><span>所有癌症类型中上调表达</span></strong></p><p><span>，而</span></p><p><p><strong><span>ITGA5和TGM2</span></strong></p></p><p><span>在</span></p><p><p><strong><span>70％的肿瘤中上调表达。</span></strong></p></p><p></p></section><section><p><span>最后，探究</span></p><p><strong><span>这三个基因与患者的生存预后的关系</span></strong></p><p><span>。发现</span></p><p><strong><span>FSCN1和ITGA5</span></strong></p><p><span>的高表达与超过10种癌症的预后不良相关，而TGM2的高表达也与超过五种癌症的不良预后相关。</span></p></section><section><p><span>总体而言，来自</span></p><p><strong><span>EC.SENESCENCE.SIG</span></strong></p><p><span>的这三个核心基因可能成为</span></p><p><strong><span>预后的全癌生物标志物</span></strong></p><p><span>。</span></p></section><p><img data-ratio="1.0243055555555556" data-s="300,640" data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/uR5O2f9J2LuY7BEZrtcceaY2Deoo5YjC1ibibPq8jJvXUHSMf6TQOHJSHoPzaNNRqJ5rgwsAfDdmTuTSRYvNFmRA/640?wx_fmt=png" data-type="png" data-w="864" src="https://mmbiz.qpic.cn/sz_mmbiz_png/uR5O2f9J2LuY7BEZrtcceaY2Deoo5YjC1ibibPq8jJvXUHSMf6TQOHJSHoPzaNNRqJ5rgwsAfDdmTuTSRYvNFmRA/640?wx_fmt=png"></p><section data-role="title" data-tools="135编辑器" data-id="132406"><section><section><section><span><strong>PART.</strong><strong>0</strong><strong data-original-title="" title="">3</strong></span></section><section><section><section><section><br></section><section><br></section></section><section><span><strong data-brushtype="text">研究结论</strong></span></section><section><section><br></section><section><br></section></section></section></section></section></section></section><section><p><span></span></p><span lang="EN-US"><p></p></span></section><p><p><span>通过大规模的</span></p><p><strong><span>泛癌单细胞数据集</span></strong></p><p><span>探究了内皮细胞的衰老状态，然后生成了</span></p><p><strong><span>肿瘤内皮细胞衰老特征指标（EC.SENESCENCE.SIG）</span></strong></p><p><span>，并基于EC.SENESCENCE.SIG构建了</span></p><p><strong><span>泛癌的免疫治疗预测模型和肿瘤预后模型</span></strong></p><p><span>。</span></p></p><section data-role="title" data-tools="135编辑器" data-id="132155"><section><section><section><section><svg xmlns="http://www.w3.org/2000/svg" width="100%" height="100%" viewbox="0 0 36.031 35" data-height="100%"><path d="M484,1626.99l-3.441,3.41,11.722,11.47,3.441-3.4Z" transform="translate(-465.938 -1627)"></path><path d="M483.99,1662.01l-3.479-3.45,11.852-11.62,3.479,3.44Z" transform="translate(-465.938 -1627)"></path><path d="M498.513,1640.89l-3.455,3.4,3.455,3.4,3.455-3.4Z" transform="translate(-465.938 -1627)"></path><path d="M492.386,1640.89l-3.456,3.4,3.456,3.4,3.455-3.4Z" transform="translate(-465.938 -1627)"></path><path d="M486.258,1640.89l-3.456,3.4,3.456,3.4,3.455-3.4Z" transform="translate(-465.938 -1627)"></path><path d="M480.9,1640.89l-3.455,3.4,3.455,3.4,3.456-3.4Z" transform="translate(-465.938 -1627)"></path><path d="M475.534,1640.89l-3.455,3.4,3.455,3.4,3.456-3.4Z" transform="translate(-465.938 -1627)"></path><path d="M469.407,1640.89l-3.456,3.4,3.456,3.4,3.455-3.4Z" transform="translate(-465.938 -1627)"></path></svg></section></section><section><p><span><strong data-brushtype="text">小编有话说</strong></span></p></section><section><section><svg xmlns="http://www.w3.org/2000/svg" width="100%" height="100%" viewbox="0 0 36.031 35" data-height="100%"><path d="M484,1626.99l-3.441,3.41,11.722,11.47,3.441-3.4Z" transform="translate(-465.938 -1627)"></path><path d="M483.99,1662.01l-3.479-3.45,11.852-11.62,3.479,3.44Z" transform="translate(-465.938 -1627)"></path><path d="M498.513,1640.89l-3.455,3.4,3.455,3.4,3.455-3.4Z" transform="translate(-465.938 -1627)"></path><path d="M492.386,1640.89l-3.456,3.4,3.456,3.4,3.455-3.4Z" transform="translate(-465.938 -1627)"></path><path d="M486.258,1640.89l-3.456,3.4,3.456,3.4,3.455-3.4Z" transform="translate(-465.938 -1627)"></path><path d="M480.9,1640.89l-3.455,3.4,3.455,3.4,3.456-3.4Z" transform="translate(-465.938 -1627)"></path><path d="M475.534,1640.89l-3.455,3.4,3.455,3.4,3.456-3.4Z" transform="translate(-465.938 -1627)"></path><path d="M469.407,1640.89l-3.456,3.4,3.456,3.4,3.455-3.4Z" transform="translate(-465.938 -1627)"></path></svg></section></section></section></section></section><p><p></p><p></p><p><p><strong><span>公共数据库纯生信数据挖掘</span></strong></p></p><p></p><p></p><p><span>，还能发到</span></p><p><strong><span>10+</span></strong></p><p><span>的文章，现在已经很少了。该文章</span></p><p></p><p><strong><span>最大的加分项</span></strong></p><p></p><p><span>就是</span></p><p><strong><span>大规模的单细胞数据的生信挖掘</span></strong></p><p><span>（15个癌种的18个单细胞数据集）。</span></p></p><p><p><span>所以说就算是公共数据，</span></p><p><strong><span>单细胞的数据还是比bulk RNA数据的含金量（可挖掘的生物学信息）要更高，更有价值</span></strong></p><p><span>！</span></p></p><p><p><span>当然，要探究肿瘤的预后肯定还是离不了</span></p><p><strong><span>与有临床信息的bulk RNA数据进行联合</span></strong></p><p><span>。</span></p></p><hr><section><span>如果大家对这类</span><span><strong>简单生信分析</strong></span><span>+</span><span><strong>研究思路拓展</strong></span><span>发高分文章的方向感兴趣，可以联系作者（扫描下方二维码添加小秘书）。</span></section><section data-tools="135编辑器" data-id="130533"><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><section><section data-role="splitline" data-tools="135编辑器" data-id="127772"><p><span>-广告-</span></p><p><img data-backh="394" data-backw="558" data-galleryid="" data-ratio="0.7065527065527065" data-s="300,640" data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/uR5O2f9J2Ls7KaPdobh1zjAeaibo9mMHhCWpF6VaDKJCuWcgYEFmNLscUKtibtYKFHfQnQof7t9RAI7x0QBeKv3Q/640?wx_fmt=png&amp;wxfrom=5&amp;wx_lazy=1&amp;wx_co=1" data-type="png" data-w="702" src="https://mmbiz.qpic.cn/sz_mmbiz_png/uR5O2f9J2Ls7KaPdobh1zjAeaibo9mMHhCWpF6VaDKJCuWcgYEFmNLscUKtibtYKFHfQnQof7t9RAI7x0QBeKv3Q/640?wx_fmt=png&amp;wxfrom=5&amp;wx_lazy=1&amp;wx_co=1"></p></section></section></section></section></section></section><section><mp-common-profile data-pluginname="mpprofile" data-id="Mzg5MjE5Mjc0Mw==" data-headimg="http://mmbiz.qpic.cn/mmbiz_png/uR5O2f9J2LtRZ4v6Ribf11IMcgNvC4HV26K1M6kC6sfyJGht49VsdVZGTIgicthMmftjjW2H7JvvvM0cic81uFy5w/0?wx_fmt=png" data-nickname="i生信" data-alias="" data-signature="专注生物分析最前沿，定期为大家解读最新高分经典生信文章，为大家提供生信分析思路和套路，方便大家短平快发SCI。" data-from="2" data-is_biz_ban="0" data-origin_num="234" data-isban="0" data-biz_account_status="0" data-index="0"></mp-common-profile></section><p><strong>阅读推荐：<a target="_blank" href="http://mp.weixin.qq.com/s?__biz=Mzg5MjE5Mjc0Mw==&amp;mid=2247497692&amp;idx=1&amp;sn=0aca86bfd9bf7679505a61ce8500803d&amp;chksm=cfc36554f8b4ec42cbb429794ca451cc7e068e020f7fa79d976f9fff1b7c9eb2ce11e4bb19f2&amp;scene=21#wechat_redirect" textvalue="这个精专的血液病研究数据库，你需要知道！" linktype="text" imgurl="" imgdata="null" data-itemshowtype="0" tab="innerlink" data-linktype="2" hasload="1"></a></strong></p><ul><li><p><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=Mzg5MjE5Mjc0Mw==&amp;mid=2247501159&amp;idx=1&amp;sn=c0b6cf71c84af026c630bf62e6d10d4d&amp;chksm=cfc357eff8b4def9f62559d26bd38935f9b4ac5bc25402f0f79d83c665b037d0e433bf824ba2&amp;scene=21#wechat_redirect" textvalue="容易复现+无实验的发SCI方法？这个热点生‍信分析思路不容错过！" linktype="text" imgurl="" imgdata="null" data-itemshowtype="0" tab="innerlink" data-linktype="2"><strong>IF 6.5/Q1 | 非肿瘤的“生信+轻实验”，南方医科大学的动脉粥样硬化研究发现思路学起来</strong></a></p></li><li><p><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=Mzg5MjE5Mjc0Mw==&amp;mid=2247501139&amp;idx=1&amp;sn=9c43e31183a6f624ee9995fa4bc36d70&amp;chksm=cfc357dbf8b4decdc51499e0e5c6e182a8fce0e164c214a02881fb5349ca891f6a43c5c5e779&amp;scene=21#wechat_redirect" textvalue="IF 7+的非肿瘤免疫分析怎么做？这篇冠‍心病研究思路教你设计国自然基础" linktype="text" imgurl="" imgdata="null" data-itemshowtype="0" tab="innerlink" data-linktype="2"><strong>全球范围首次！高分国际期刊发表癌症单细胞RNA编辑重要成果！快跟着学生信优秀思路</strong></a></p></li><li><p><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=Mzg5MjE5Mjc0Mw==&amp;mid=2247501110&amp;idx=1&amp;sn=8b904cb022efacb0206f4c5052976b0b&amp;chksm=cfc357bef8b4dea8dd4e111a0e87715c4f864d8e26db1d03bc8b05915b2701eaa3b4831e1560&amp;scene=21#wechat_redirect" textvalue="单细胞肿瘤预后，这篇湘雅医院的IF 8+思‍路可以Get！" linktype="text" imgurl="" imgdata="null" data-itemshowtype="0" tab="innerlink" data-linktype="2"><strong>线粒体相关的肿瘤风险评估，看这篇IF 7+如何展开“AI研究”</strong></a></p></li></ul><p><mp-style-type data-value="3"></mp-style-type></p></div>  
<hr>
<a href="https://mp.weixin.qq.com/s/AaI2-pNmqjPAo0x9VCCnEQ",target="_blank" rel="noopener noreferrer">原文链接</a>
